Related Experiment Video
Updated: Jul 24, 2026

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
Intraperitoneal blood exacerbates the remote inflammatory response to murine peritonitis
J L Johnson1, B H Wallace, C D Mareen
1Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Background:
This study investigated the effects of intra-abdominal blood on the systemic response to peritonitis using a murine model of hemorrhage, peritonitis, and multiple organ dysfunction syndrome.
Methods:
The model used male ICR mice subjected to hemorrhage and intraperitoneal zymosan. Half of the mice received intraperitoneal blood. Outcome measures included lung myeloperoxidase, lung edema, lung injury score, and plasma and lung tissue chemokine production.
Results:
Peritoneal blood (in association with peritoneal inflammation) increased lung neutrophil sequestration (myeloperoxidase) (2.56 +/- 1.42 vs. 1.45 +/- 0.49 U/left lung, p = 0.04) and lung weight (0.11 +/- 0.04 vs. 0.07 +/- 0.02 g/left lung, p = 0.02), and was associated with significantly higher chemokine levels in plasma (KC and MCP-1) and lung tissue (KC, MIP-2, and MCP-1). Both plasma and lung tissue neutrophil chemoattractants KC and MIP-2 were significantly linearly correlated with myeloperoxidase (p < 0.009), and lung tissue KC (a neutrophil chemokine) and MCP-1 and MIP-1alpha (mononuclear cell chemokines) correlated with lung injury score (p < 0.003).
Conclusion:
Although blood alone in the peritoneal cavity was well tolerated, in conjunction with inflammation, it was synergistic in amplifying the systemic inflammatory response. The amplified lung injury in this model was associated with significant increases in circulating and lung tissue chemokine concentrations.
Insights
Intra-abdominal blood, combined with inflammation, significantly amplifies the systemic inflammatory response and lung injury in mice. This amplified injury is linked to increased circulating and lung tissue chemokine levels.
Area of Science:
- Inflammation and Immunology
- Sepsis Pathophysiology
- Hemorrhage and Organ Injury
Background:
- Investigating the systemic inflammatory response to peritonitis.
- Utilizing a murine model for hemorrhage, peritonitis, and multiple organ dysfunction syndrome.
Purpose of the Study:
- To determine the effects of intra-abdominal blood on the systemic response to peritonitis.
- To elucidate the role of chemokines in amplified lung injury.
Main Methods:
- Male ICR mice subjected to hemorrhage and intraperitoneal zymosan.
- Experimental group received intraperitoneal blood; control group did not.
- Measured lung myeloperoxidase, edema, injury score, and chemokine production.
Main Results:
- Peritoneal blood with inflammation increased lung neutrophil sequestration and weight.
- Significantly higher plasma and lung tissue chemokine levels (KC, MCP-1, MIP-2) were observed.
- Neutrophil chemoattractants correlated with myeloperoxidase and lung injury scores.
Conclusions:
- Blood in the peritoneal cavity, when combined with inflammation, synergistically amplifies the systemic inflammatory response.
- Amplified lung injury was associated with elevated circulating and lung tissue chemokine concentrations.
- Findings highlight the complex interplay between hemorrhage, inflammation, and organ injury.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Inflammation III: Local and Systemic Effects
Inflammatory Bowel Disease III: Crohn's Disease

